XML 106 R83.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Acquistions and Disposals - Additional Information (Details) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 Months Ended | 12 Months Ended |  |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jan. 24, 2018 CAD ($) shares $ / shares | Dec. 31, 2017 CAD ($) | Dec. 18, 2017 CAD ($) ft² | Dec. 05, 2017 CAD ($) ft² | Dec. 01, 2017 | Nov. 30, 2017 CAD ($) | Oct. 10, 2017 | Sep. 20, 2017 | Sep. 06, 2017 CAD ($) | Aug. 28, 2017 CAD ($) $ / shares shares | May 01, 2017 CAD ($) $ / shares shares | Mar. 31, 2017 CAD ($) shares | Jan. 31, 2017 CAD ($) shares $ / shares | Dec. 12, 2016 CAD ($) shares | Nov. 01, 2016 CAD ($) shares | Mar. 31, 2018 CAD ($) shares | Mar. 31, 2018 CAD ($) shares | Mar. 31, 2017 CAD ($) shares $ / shares | Feb. 07, 2018 shares | Jan. 31, 2018 CAD ($) | Nov. 23, 2017 shares | Sep. 07, 2017 CAD ($) shares | Mar. 30, 2017 CAD ($) | Mar. 31, 2016 CAD ($) shares
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of voting equity interests acquired |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% | 0.00% |  |  |  |  |  |  |
Name of joint operation |  |  |  |  |  |  | BC Tweed Joint Venture Inc. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase price of property |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 176,037,000 | $ 29,391,000 |  |  |  |  |  |
Transfer of Vert Mirabel investment to Canopy Rivers |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 964,000 |  |  |  |  |  |  |
Proceeds from issuance of common shares and warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 470,670,000 | $ 130,276,000 |  |  |  |  |  |
Number of common shares issued | shares |  |  |  |  |  |  |  |  |  |  |  | 162,187,262 |  |  |  | 199,320,981 | 199,320,981 | 162,187,262 | 117,253 |  |  |  |  | 98,818,213
Consideration paid in cash |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 6,000,000 |  |
common shares issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 490,641 |  |  |  |  |  |  |  | 111,366 |  |
Goodwill |  |  |  |  |  |  |  |  |  |  |  | $ 241,371,000 |  |  |  | $ 314,923,000 | $ 314,923,000 | $ 241,371,000 |  |  |  |  |  | $ 20,866,000
Agripharm Corp. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proportion of ownership interest in subsidiary |  |  |  |  | 40.00% | 100.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill |  |  |  |  |  | $ 2,259,000 |  |  |  |  |  |  |  |  |  | 2,259,000 | 2,259,000 |  |  |  |  |  |  |
Transaction costs included in carrying value of investment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 311,000 |  |  |  |  |  |  |
Products agreed to sell by consolidated entity percent |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 100.00% |  |  |  |  |  |  |
Percent of products sold by consolidated entity in retail location |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25.00% |  |  |  |  |  |  |
Royalty term |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 20 years |  |  |  |  |  |  |
Advance under royalty agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 3,000,000 |  |  |  |  |  |  |
Percentage of acquisition through Warrant |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4.00% |  |  |  |  |  |  |
Consideration to be paid through warrant exercise |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 5,000,000 |  |  |  |  |  |  |
Warrant expiration date |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | November 16, 2020 |  |  |  |  |  |  |
Fair value of the warrant estimated by black-scholes model |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 586,000 | $ 586,000 |  |  |  |  |  |  |
Receivable under the royalty agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,000,000 | 3,000,000 |  |  |  |  |  |  |
Amount allocated to the royalty receivable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,414,000 | 2,414,000 |  |  |  |  |  |  |
Canopy Rivers |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,579,000 | $ 0 |  |  |  |  |  |
Maximum | Agripharm Corp. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Advance under repayable debentures and royalty agreement total |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 20,000,000 |  |  |  |  |  |  |
Vert Mirabel |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Profit loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,411,000 |  |  |  |  |  |  |
Share-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,131,000 |  |  |  |  |  |  |
Name of venture |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Vert Mirabel |  |  |  |  |  |  |
Place in business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Quebec |  |  |  |  |  |  |
Ownership interest |  |  | 40.70% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase price of property |  |  | $ 20,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of increase property |  |  | 3.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License agreement period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |
Fair value of put option estimated using discounted cash flow approach |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 3,750,000 |  |  |  |  |  |  |
Put liability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 4,850,000 | 4,850,000 |  |  |  |  |  |  |
Changes in fair value of put liability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,100,000 |  |  |  |  |  |  |
Cash contributed to exchange of preference share |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 15,000,000 |  |  |  |  |  |  |
Cumulative preferred dividends |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 750,000 |  |  |  |  |  |  |
Preferred dividend rate |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 18.00% |  |  |  |  |  |  |
Proceeds from issuance of common shares and warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 2,750,000 |  |  |  |  |  |  |
Fair value grant date discount value |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,599,000 |  |  |  |  |  |  |
Acquisition related costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 54,000 |  |  |  |  |  |  |
Vert Mirabel | Investments Accounted for Using Equity Method |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of voting equity interests acquired |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 100.00% | 100.00% |  |  |  |  |  |  |
Vert Mirabel | Property Plant and Equipment under Operating Leases |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Area of Greenhouse | ft² |  |  | 700,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vert Mirabel | Canopy Rivers |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proportion of ownership interest in subsidiary |  |  | 26.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vert Mirabel | Les Serres Vert Cannabis Inc |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proportion of ownership interest held by non-controlling interest |  |  | 33.30% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vert Mirabel | Minimum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase price of property |  |  | $ 23,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Green Hemp Industries Ltd |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Name of acquiree | Green Hemp Industries Ltd |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Date of acquisition | Jan. 24, 2018 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share issue price | $ / shares | $ 34.87 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total consideration | $ 1,023,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-based compensation expense | 857,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Consideration paid in shares | 857,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Consideration paid in cash | $ 166,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
common shares issued | shares | 24,577 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
R Trees |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Name of acquiree |  |  |  |  |  |  |  |  |  |  | Tweed Grasslands Cannabis Inc. (formerly rTrees) |  |  |  |  |  |  |  |  |  |  |  |  |
Date of acquisition |  |  |  |  |  |  |  |  |  |  | May 01, 2017 |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of voting equity interests acquired |  |  |  |  |  |  |  |  |  |  | 100.00% |  |  |  |  |  |  |  |  |  |  |  |  |
Common shares issued | shares |  |  |  |  |  |  |  |  |  |  | 3,494,505 |  |  |  |  |  |  |  |  |  |  |  |  |
common shares held in escrow | shares |  |  |  |  |  |  |  |  |  |  | 2,795,604 |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued | shares |  |  |  |  |  |  |  |  |  |  | 698,901 |  |  |  |  |  |  |  |  |  |  |  |  |
Share issue price | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 9.13 |  |  |  |  |  |  |  |  |  |  |  |  |
Equity consideration |  |  |  |  |  |  |  |  |  |  | $ 6,381,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Gross contingent consideration |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 25,524,000 |  |  |  |  |  |  |
Contingent consideration fair value |  |  |  |  |  |  |  |  |  |  | 21,714,000 |  |  |  |  | $ 21,714,000 | 21,714,000 |  |  |  |  |  |  |
Replacement options |  |  |  |  |  |  |  |  |  |  | 1,079,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued |  |  |  |  |  |  |  |  |  |  | 1,303,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Effective settlement of receivable |  |  |  |  |  |  |  |  |  |  | 450,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Total consideration |  |  |  |  |  |  |  |  |  |  | $ 30,927,000 |  |  |  |  | 30,927,000 | 30,927,000 |  |  |  |  |  |  |
Profit loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,565,000 |  |  |  |  |  |  |  |
Consideration paid in shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6,381,000 | 6,381,000 |  |  |  |  |  |  |
Consideration paid in cash |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 450,000 | 450,000 |  |  |  |  |  |  |
Cash and cash equivalents |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 59,000 | 59,000 |  |  |  |  |  |  |
Goodwill |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 29,736,000 | $ 29,736,000 |  |  |  |  |  |  |
Warrant expiration date |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | April 30, 2018 |  |  |  |  |  |  |
Tweed JA |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Name of acquiree |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Tweed JA |  |  |  |  |  |  |
Date of acquisition |  |  |  |  |  |  |  |  | Sep. 06, 2017 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total consideration |  |  |  |  |  |  |  |  | $ 3,769,000 |  |  |  |  |  |  | 3,769,000 | $ 3,769,000 |  |  |  |  |  |  |
Profit loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 391,000 |  |  |  |  |  |  |
Percentage of equity financial interest |  |  |  |  |  |  |  |  | 49.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Subscription receivable |  | $ 2,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Consideration paid in cash |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 100,000 | 100,000 |  |  |  |  |  |  |
Cash and cash equivalents |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 125,000 | 125,000 |  |  |  |  |  |  |
Goodwill |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,835,000 | 1,835,000 |  |  |  |  |  |  |
Spectrum Cannabis Denmark ApS |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total consideration |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,228,000 | 3,228,000 |  |  |  |  |  |  |
Profit loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,772,000 |  |  |  |  |  |  |
Name of joint operation |  |  |  |  |  |  |  | Spectrum Cannabis Denmark ApS |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Principal place of business |  |  |  |  |  |  |  | Europe |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proportion of ownership interest in subsidiary |  |  |  |  |  |  |  | 62.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proportion of ownership interest held by non-controlling interest |  |  |  |  |  |  |  | 38.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares transferred | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,906,214 |  |  |  |  |  |  |
Vesting period of exchange |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4 years |  |  |  |  |  |  |
Cost to purchase remaining interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 6,000,000 |  |  |  |  |  |  |
Fair value options granted |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 18,805,000 | 18,805,000 |  |  |  |  |  |  |
Share-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 7,206,000 |  |  |  |  |  |  |
Operating facility acquired | ft² |  |  |  | 40,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash Paid As Consideration Adjusted Amount |  |  |  | $ 3,228,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gain on bargain purchase |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 638,000 |  |  |  |  |  |  |
Consideration paid in cash |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 3,228,000 | $ 3,228,000 |  |  |  |  |  |  |
Spot Therapeutics Inc. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Name of acquiree |  |  |  |  |  |  |  |  |  | Spot Therapeutics Inc. |  |  |  |  |  |  |  |  |  |  |  |  |  |
Date of acquisition |  |  |  |  |  |  |  |  |  | Aug. 28, 2017 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of voting equity interests acquired |  |  |  |  |  |  |  |  |  | 100.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share issue price | $ / shares |  |  |  |  |  |  |  |  |  | $ 8.90 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-based compensation expense |  |  |  |  |  |  |  |  |  | $ 844,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of common shares issued | shares |  |  |  |  |  |  |  |  |  | 111,669 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Consideration paid in shares |  |  |  |  |  |  |  |  |  | $ 993,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Consideration paid in cash |  |  |  |  |  |  |  |  |  | $ 907,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Mettrum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of voting equity interests acquired |  |  |  |  |  |  |  |  |  |  |  |  | 100.00% |  |  |  |  |  |  |  |  |  |  |
Share issue price | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  | $ 9.85 |  |  |  |  | $ 11.93 |  |  |  |  |  |
Equity consideration |  |  |  |  |  |  |  |  |  |  |  |  | $ 337,511,000 |  |  |  |  |  |  |  |  |  |  |
Replacement options |  |  |  |  |  |  |  |  |  |  |  |  | 11,663,000 |  |  |  |  |  |  |  |  |  |  |
Total consideration |  |  |  |  |  |  |  |  |  |  |  | 350,334,000 | 350,334,000 |  |  |  |  | $ 350,334,000 |  |  |  |  |  |
Profit loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4,053,000 |  |  |  |  |  |
Share-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  | $ 480,000 |  |  |  |  |  |  |  |  |  |  |
Acquisition related costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,190,000 |  |  |  |  |  |
Consideration paid in shares |  |  |  |  |  |  |  |  |  |  |  | $ 337,511,000 |  |  |  |  |  | $ 337,511,000 |  |  |  |  |  |
common shares issued | shares |  |  |  |  |  |  |  |  |  |  |  | 83,822 | 34,265,042 |  |  |  |  | 83,822 |  |  |  |  |  |
Cash and cash equivalents |  |  |  |  |  |  |  |  |  |  |  | $ 12,309,000 | $ 12,309,000 |  |  |  |  | $ 12,309,000 |  |  |  |  |  |
Settlement of accounts receivable |  |  |  |  |  |  |  |  |  |  |  |  | $ 680,000 |  |  |  |  |  |  |  |  |  |  |
Options exchanged ratio |  |  |  |  |  |  |  |  |  |  |  |  | 0.7132% |  |  |  |  |  |  |  |  |  |  |
Changes in fair value of biological assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,659,000 |  |  |  |  |  |
Changes in Revenue |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,033,000 |  |  |  |  |  |
Revenue of acquiree |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 15,428,000 |  |  |  |  |  |
Profit loss of acquiree |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 12,673,000 |  |  |  |  |  |
Acquisition of accounts receivable |  |  |  |  |  |  |  |  |  |  |  |  | $ 680,000 |  |  |  |  |  |  |  |  |  |  |
Goodwill |  |  |  |  |  |  |  |  |  |  |  | 207,081,000 |  |  |  |  |  | 207,081,000 |  |  |  |  |  |
Mettrum | Common Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity consideration |  |  |  |  |  |  |  |  |  |  |  | 1,000,000 |  |  |  |  |  | 1,000,000 |  |  |  |  |  |
MedCann |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of voting equity interests acquired |  |  |  |  |  |  |  |  |  |  |  |  |  | 100.00% |  |  |  |  |  |  |  |  |  |
Equity consideration |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 6,746,000 |  |  |  |  |  |  |  |  |  |
Contingent consideration fair value |  |  |  |  |  |  |  |  |  |  |  | 688,000 |  |  |  |  |  | 688,000 |  |  |  |  |  |
Total consideration |  |  |  |  |  |  |  |  |  |  |  | 10,408,000 |  | $ 3,660,000 |  |  |  | 10,408,000 |  |  |  |  |  |
Profit loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 462,000 |  |  |  |  |  |
Consideration paid in shares |  |  |  |  |  |  |  |  |  |  |  | 9,720,000 |  |  |  |  |  | 9,720,000 |  |  |  |  |  |
Changes in Revenue |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 106,000 |  |  |  |  |  |
Revenue of acquiree |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 35,000 |  |  |  |  |  |
Profit loss of acquiree |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 542,000 |  |  |  |  |  |
Common shares issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 674,631 |  |  |  |  |  |  |  |  |  |
Contingent consideration |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 4,906,000 |  |  |  |  |  |  |  |  |  |
Goodwill |  |  |  |  |  |  |  |  |  |  |  | 9,209,000 |  |  |  |  |  | 9,209,000 |  |  |  |  |  |
MedCann | Escrow |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
common shares issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,165,272 |  | 122,660 | 122,660 |  |  |  | 367,981 |  |  |
Vert Medical Inc Green Medical Inc |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of voting equity interests acquired |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 100.00% |  |  |  |  |  |  |  |  |
Number of shares issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 58,978 |  |  |  |  |  |  |  |  |
Equity consideration |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 498,000 |  |  |  |  |  |  |  |  |
common shares issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 294,900 |  |  |  |  |  |  |  |  |
Contingent consideration |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,651,000 |  |  |  |  |  |  |  |  |
Contingent consideration fair value |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,251,000 |  |  |  |  |  |  |  |  |
Vert Medical Inc Green Medical Inc | Escrow |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity consideration |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 413,000 |  |  |  |  |  |  |  |  |
common shares issued |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 235,922 | 88,469,000 | 88,469,000 |  |  | 147,453,000 |  |  |  |
Hemp |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of voting equity interests acquired |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 75.00% |  |  |  |  |  |  |  |  |
Equity consideration |  |  |  |  |  |  |  |  |  |  |  | $ 903,000 |  |  | $ 595,000 |  |  | 903,000 |  |  |  |  |  |
Total consideration |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,344,000 |  |  |  |  |  |  |  |  |
Proportion of ownership interest held by non-controlling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25.00% |  |  |  |  |  |  |
Consideration paid in cash |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 338,000 |  |  |  |  |  |  |  | $ 295,000 |
Common shares issued | shares |  |  |  |  |  |  |  |  |  |  |  | 129,016 |  |  |  |  |  |  |  |  |  |  |  |
Hemp | Escrow |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity consideration |  |  |  |  |  |  |  |  |  |  |  | $ 808,000 |  |  | $ 808,000 |  |  | $ 808,000 |  |  |  |  |  |
common shares issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 129,016 |  |  |  |  |  |  |  |  |
Hemp | Maximum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure Of Business Combinations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
common shares issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 258,037 |  |  |  |  |  |  |  |  |

X
- Definition Acquisition consideration equity value. + References No definition available. + Details
Name: | cgc_AcquisitionConsiderationEquityValue
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Acquisition percentage through warrant. + References No definition available. + Details
Name: | cgc_AcquisitionPercentageThroughWarrant
Namespace Prefix: | cgc_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Advance under repayable debentures and royalty agreement total. + References No definition available. + Details
Name: | cgc_AdvanceUnderRepayableDebenturesAndRoyaltyAgreementTotal
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Advance under royalty agreement. + References No definition available. + Details
Name: | cgc_AdvanceUnderRoyaltyAgreement
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount allocated to the royalty receivable. + References No definition available. + Details
Name: | cgc_AmountAllocatedToRoyaltyReceivable
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Area of operating facility acquired. + References No definition available. + Details
Name: | cgc_AreaOfOperatingFacilityAcquired
Namespace Prefix: | cgc_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Area of operating facility used. + References No definition available. + Details
Name: | cgc_AreaOfOperatingFacilityUsed
Namespace Prefix: | cgc_
Data Type: | num:areaItemType
Balance Type: | na
Period Type: | instant

X
- Definition Business acquisition equity portion of purchase consideration shares. + References No definition available. + Details
Name: | cgc_BusinessAcquisitionEquityPortionOfPurchaseConsiderationsShares
Namespace Prefix: | cgc_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business acquisition number of shares issued. + References No definition available. + Details
Name: | cgc_BusinessAcquisitionNumberOfSharesIssued
Namespace Prefix: | cgc_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cash contribute to exchange of preference share. + References No definition available. + Details
Name: | cgc_CashContributeToExchangeOfPreferenceShare
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Cash transferred in business combination net of cash acquired. + References No definition available. + Details
Name: | cgc_CashTransferredInBusinessCombinationNetOfCashAcquired
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Consideration to be paid through future warrant exercise. + References No definition available. + Details
Name: | cgc_ConsiderationToBePaidThroughWarrantExercise
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Contingent consideration fair value at acquisition. + References No definition available. + Details
Name: | cgc_ContingentConsiderationFairValueAtAcquisition
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The cost to be paid to acquire the remaining interest in the entity. + References No definition available. + Details
Name: | cgc_CostToPurchaseRemainingInterest
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Dividends percentage on preferred stock. + References No definition available. + Details
Name: | cgc_DividendsPercentageOnPreferredStock
Namespace Prefix: | cgc_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity portion of purchase consideration shares held in escrow. + References No definition available. + Details
Name: | cgc_EquityPortionOfPurchaseConsiderationSharesHeldInEscrow
Namespace Prefix: | cgc_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity portion of purchase consideration shares released from escrow. + References No definition available. + Details
Name: | cgc_EquityPortionOfPurchaseConsiderationSharesReleasedFromEscrow
Namespace Prefix: | cgc_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value at measurement date share options granted. + References No definition available. + Details
Name: | cgc_FairValueAtMeasurementDateShareOptionsGranted
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Fair value changes on put liability. + References No definition available. + Details
Name: | cgc_FairValueChangesOnPutLiability
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Fair value grant date discount value. + References No definition available. + Details
Name: | cgc_FairValueGrantDateDiscountValue
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Fair value of put liability estimated using discounted cash flow approach. + References No definition available. + Details
Name: | cgc_FairValueOfPutLiabilityEstimatedUsingDiscountedCashFlowApproach
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Fair value of the warrant estimated by black-scholes model. + References No definition available. + Details
Name: | cgc_FairValueOfWarrantEstimatedByBlackScholesModel
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Gain on bargain purchase. + References No definition available. + Details
Name: | cgc_GainLossOnBargainPurchase
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Gross value of contingent liabilities. + References No definition available. + Details
Name: | cgc_GrossValueOfContingentLiabilities
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition License agreement period. + References No definition available. + Details
Name: | cgc_LicenseAgreementPeriod
Namespace Prefix: | cgc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares transferred. + References No definition available. + Details
Name: | cgc_NumberOfSharesTransferred
Namespace Prefix: | cgc_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Options exchanged ratio. + References No definition available. + Details
Name: | cgc_OptionsExchangedRatio
Namespace Prefix: | cgc_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Other consideration replacement options + References No definition available. + Details
Name: | cgc_OtherConsiderationReplacementOptions
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Other consideration replacement warrants. + References No definition available. + Details
Name: | cgc_OtherConsiderationsReplacementWarrants
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Percent of products sold by consolidated entity in retail location. + References No definition available. + Details
Name: | cgc_PercentOfProductsSoldByConsolidatedEntityInRetailLocation
Namespace Prefix: | cgc_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The percentage of financial interest acquired in a business combination. + References No definition available. + Details
Name: | cgc_PercentageOfEquityFinancialInterest
Namespace Prefix: | cgc_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage of increase property purchase price. + References No definition available. + Details
Name: | cgc_PercentageOfIncreasePropertyPurchasePrice
Namespace Prefix: | cgc_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Portion of subscription price advanced + References No definition available. + Details
Name: | cgc_PortionOfSubscriptionPriceAdvanced
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Products agreed to sell by consolidated entity percent. + References No definition available. + Details
Name: | cgc_ProductsAgreedToSellByConsolidatedEntityPercent
Namespace Prefix: | cgc_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Put liability. + References No definition available. + Details
Name: | cgc_PutLiability
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Receivable under the royalty agreement. + References No definition available. + Details
Name: | cgc_ReceivableUnderRoyaltyAgreement
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Royalty term. + References No definition available. + Details
Name: | cgc_RoyaltyTerm
Namespace Prefix: | cgc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Settlement of accounts receivable acquired through business combination. + References No definition available. + Details
Name: | cgc_SettlementOfAccountsReceivableAsPartOfAcquisitionConsideration
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Share issue price. + References No definition available. + Details
Name: | cgc_ShareIssuePrice
Namespace Prefix: | cgc_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Share purchase plan contribution vesting period. + References No definition available. + Details
Name: | cgc_SharePurchasePlanContributionVestingPeriod
Namespace Prefix: | cgc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Shares held in escrow account. + References No definition available. + Details
Name: | cgc_SharesHeldInEscrowAccount
Namespace Prefix: | cgc_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Transaction costs. + References No definition available. + Details
Name: | cgc_TransactionCosts
Namespace Prefix: | cgc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Warrant expiration date. + References No definition available. + Details
Name: | cgc_WarrantExpirationDate
Namespace Prefix: | cgc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B64 -Subparagraph f -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B64_f&doctype=Appendix&seq=2 -URIDate 2017-03-09 + Details
Name: | ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B64 -Subparagraph m -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B64_m&doctype=Appendix&seq=2 -URIDate 2017-03-09 + Details
Name: | ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B64 -Subparagraph i -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B64_i&doctype=Appendix&seq=2 -URIDate 2017-03-09 + Details
Name: | ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B64 -Subparagraph f -Clause i -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B64_f_i&doctype=Appendix&seq=2 -URIDate 2017-03-09 + Details
Name: | ifrs-full_CashTransferred
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The increase (decrease) in biological assets. [Refer: Biological assets] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 41 -IssueDate 2017-01-01 -Paragraph 50 -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=41&date=2017-03-01&anchor=para_50&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_ChangesInBiologicalAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount recognised as of the acquisition date for contingent consideration arrangements assumed and indemnification assets acquired in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B64 -Subparagraph g -Clause i -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B64_g_i&doctype=Appendix&seq=2 -URIDate 2017-03-09 + Details
Name: | ifrs-full_ContingentConsiderationArrangementsAndIndemnificationAssetsRecognisedAsOfAcquisitionDate
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of contingent liabilities recognised as of the acquisition date in a business combination. [Refer: Contingent liabilities [member]; Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B64 -Subparagraph i -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B64_i&doctype=Appendix&seq=2 -URIDate 2017-03-09 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph IE72 -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_IE72&doctype=Illustrative%20Examples -URIDate 2017-03-09 + Details
Name: | ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of cumulative preference dividends not recognised. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2017-01-01 -Paragraph 137 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=1&date=2017-03-01&anchor=para_137_b&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_CumulativePreferenceDividendsNotRecognised
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- Definition The date on which the acquirer obtains control of the acquiree in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B64 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B64_b&doctype=Appendix&seq=2 -URIDate 2017-03-09 + Details
Name: | ifrs-full_DateOfAcquisition2013
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfBusinessCombinationsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B64 -Subparagraph f -Clause iv -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B64_f_iv&doctype=Appendix&seq=2 -URIDate 2017-03-09 + Details
Name: | ifrs-full_EquityInterestsOfAcquirer
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of expense from share-based payment transactions with employees. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2017-01-01 -Paragraph 112 -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=1&date=2017-03-01&anchor=para_112_c&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B67 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B67_d&doctype=Appendix&seq=2 -URIDate 2017-03-09 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 36 -IssueDate 2017-01-01 -Paragraph 134 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=36&date=2017-03-01&anchor=para_134_a&doctype=Standard -URIDate 2017-03-09 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 36 -IssueDate 2017-01-01 -Paragraph 135 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=36&date=2017-03-01&anchor=para_135_a&doctype=Standard -URIDate 2017-03-09 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2017-01-01 -Paragraph 54 -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=1&date=2017-03-01&anchor=para_54_c&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_Goodwill
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The gross contractual amounts receivable for receivables acquired in business combinations. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B64 -Subparagraph h -Clause ii -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B64_h_ii&doctype=Appendix&seq=2 -URIDate 2017-03-09 + Details
Name: | ifrs-full_GrossContractualAmountsReceivableForAcquiredReceivables
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The increase (decrease) in the entity's equity resulting from the change in the equity of subsidiaries. [Refer: Subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2017-01-01 -Paragraph 106 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=1&date=2017-03-01&anchor=para_106_d&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_IncreaseDecreaseThroughChangeInEquityOfSubsidiaries
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The name of the business or businesses that the acquirer obtains control of in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B64 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B64_a&doctype=Appendix&seq=2 -URIDate 2017-03-09 + Details
Name: | ifrs-full_NameOfAcquiree
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The name of a joint operation. [Refer: Joint operations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2017-01-01 -Paragraph 21 -Subparagraph a -Clause i -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=12&date=2017-03-01&anchor=para_21_a_i&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_NameOfJointOperation
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The name of a joint venture. [Refer: Joint ventures [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2017-01-01 -Paragraph 17 -Subparagraph b -Clause i -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=27&date=2017-03-01&anchor=para_17_b_i&doctype=Standard -URIDate 2017-03-09 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2017-01-01 -Paragraph 16 -Subparagraph b -Clause i -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=27&date=2017-03-01&anchor=para_16_b_i&doctype=Standard -URIDate 2017-03-09 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2017-01-01 -Paragraph 21 -Subparagraph a -Clause i -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=12&date=2017-03-01&anchor=para_21_a_i&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_NameOfJointVenture
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B64 -Subparagraph f -Clause iv -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B64_f_iv&doctype=Appendix&seq=2 -URIDate 2017-03-09 + Details
Name: | ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares issued by the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2017-01-01 -Paragraph 106 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=1&date=2017-03-01&anchor=para_106_d&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_NumberOfSharesIssued
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B64 -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B64_c&doctype=Appendix&seq=2 -URIDate 2017-03-09 + Details
Name: | ifrs-full_PercentageOfVotingEquityInterestsAcquired
Namespace Prefix: | ifrs-full_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The principal place of business of a joint operation. [Refer: Joint operations [member]; Principal place of business] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2017-01-01 -Paragraph 21 -Subparagraph a -Clause iii -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=12&date=2017-03-01&anchor=para_21_a_iii&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_PrincipalPlaceOfBusinessOfJointOperation
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The principal place of business of a joint venture. [Refer: Principal place of business; Joint ventures [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2017-01-01 -Paragraph 16 -Subparagraph b -Clause ii -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=27&date=2017-03-01&anchor=para_16_b_ii&doctype=Standard -URIDate 2017-03-09 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2017-01-01 -Paragraph 17 -Subparagraph b -Clause ii -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=27&date=2017-03-01&anchor=para_17_b_ii&doctype=Standard -URIDate 2017-03-09 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2017-01-01 -Paragraph 21 -Subparagraph a -Clause iii -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=12&date=2017-03-01&anchor=para_21_a_iii&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_PrincipalPlaceOfBusinessOfJointVenture
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 7 -IssueDate 2017-01-01 -Paragraph 17 -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=7&date=2017-03-01&anchor=para_17&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_ProceedsFromIssueOfOrdinaryShares
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The profit (loss) of the acquiree, since the acquisition date, included in the consolidated statement of comprehensive income. [Refer: Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B64 -Subparagraph q -Clause i -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B64_q_i&doctype=Appendix&seq=2 -URIDate 2017-03-09 + Details
Name: | ifrs-full_ProfitLossOfAcquiree
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The profit (loss) of the combined entity as though the acquisition date for all business combinations that occurred during the year had been as of the beginning of the annual reporting period. [Refer: Business combinations [member]; Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B64 -Subparagraph q -Clause ii -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B64_q_ii&doctype=Appendix&seq=2 -URIDate 2017-03-09 + Details
Name: | ifrs-full_ProfitLossOfCombinedEntity
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Joint ventures [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2017-01-01 -Paragraph 17 -Subparagraph b -Clause iii -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=27&date=2017-03-01&anchor=para_17_b_iii&doctype=Standard -URIDate 2017-03-09 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2017-01-01 -Paragraph 16 -Subparagraph b -Clause iii -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=27&date=2017-03-01&anchor=para_16_b_iii&doctype=Standard -URIDate 2017-03-09 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2017-01-01 -Paragraph 21 -Subparagraph a -Clause iv -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=12&date=2017-03-01&anchor=para_21_a_iv&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_ProportionOfOwnershipInterestInJointVenture
Namespace Prefix: | ifrs-full_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2017-01-01 -Paragraph 17 -Subparagraph b -Clause iii -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=27&date=2017-03-01&anchor=para_17_b_iii&doctype=Standard -URIDate 2017-03-09 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2017-01-01 -Paragraph 16 -Subparagraph b -Clause iii -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=27&date=2017-03-01&anchor=para_16_b_iii&doctype=Standard -URIDate 2017-03-09 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2017-01-01 -Paragraph 19B -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=12&date=2017-03-01&anchor=para_19B_c&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_ProportionOfOwnershipInterestInSubsidiary
Namespace Prefix: | ifrs-full_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Subsidiaries [member]; Non-controlling interests] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2017-01-01 -Paragraph 12 -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=12&date=2017-03-01&anchor=para_12_c&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
Namespace Prefix: | ifrs-full_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 7 -IssueDate 2017-01-01 -Paragraph 16 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=7&date=2017-03-01&anchor=para_16_a&doctype=Standard -URIDate 2017-03-09 + Details
Name: | ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of revenue of the acquiree since the acquisition date included in the consolidated statement of comprehensive income. [Refer: Revenue] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B64 -Subparagraph q -Clause i -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B64_q_i&doctype=Appendix&seq=2 -URIDate 2017-03-09 + Details
Name: | ifrs-full_RevenueOfAcquiree
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The revenue of the combined entity as though the acquisition date for all business combinations that occurred during the year had been as of the beginning of the annual reporting period. [Refer: Business combinations [member]; Revenue] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B64 -Subparagraph q -Clause ii -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B64_q_ii&doctype=Appendix&seq=2 -URIDate 2017-03-09 + Details
Name: | ifrs-full_RevenueOfCombinedEntity
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of contingent liabilities recognised in a business combination that were settled. [Refer: Contingent liabilities recognised in business combination] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2017-01-01 -Paragraph B67 -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B67_c&doctype=Appendix&seq=2 -URIDate 2017-03-09 + Details
Name: | ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | ifrs-full_ConsolidatedStructuredEntitiesAxis=cgc_AgripharmCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_JointVenturesAxis=cgc_CanopyRiversMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=cgc_VertMirabelMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfAssetsAxis=ifrs-full_InvestmentsAccountedForUsingEquityMethodMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_PropertyPlantAndEquipmentUnderOperatingLeasesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_JointVenturesAxis=cgc_LesSerresStephaneBertrandIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=cgc_GreenHempIndustriesLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=cgc_RTreesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=cgc_TweedJAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=cgc_SpectrumCannabisDenmarkApSMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=cgc_SpotTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=cgc_MettrumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=cgc_MedCannGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfAcquiredReceivablesAxis=cgc_EscrowMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=cgc_VertMedicalIncGreenMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=cgc_HempCAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |